Views & Analysis Never waste a crisis: Can a new life sciences strategy be f... Andrew McConaghie speaks to UK pharma industry leaders about Brexit and what is needed to create a meaningful, long-term life sciences strategy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face